Skip to main content

Animations

MJFF Publications

4721 - 4730 of 8459 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8
    Best OA location URL:
    Citation Count: 105
  • Summary Details
    OPEN
    Title: Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.25811
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Genetic variants and functional pathways associated with resilience to Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awaa209
    Citation Count: 115
  • Summary Details
    RESTRICTED
    Title: LRRK2 Phosphorylation, More Than an Epiphenomenon
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00527
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom10060912
    Citation Count: 21
  • Summary Details
    OPEN
    Title: β-Glucocerebrosidase activity in GBA -linked Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000009989
    Citation Count: 38
  • Summary Details
    OPEN
    Title: ATP10B and the risk for Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-020-02172-4
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-04897-6
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Neural activity in functional movement disorders after inpatient rehabilitation
    Journal Name: Psychiatry Research: Neuroimaging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pscychresns.2020.111125
    Best OA location URL:
    Citation Count: 22
  • Summary Details
    OPEN
    Title: White Matter Hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13000
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.